2-MeS-β,γ-CCl2-ATP is a Potent Agent for Reducing Intraocular Pressure
dc.contributor.author | Eliahu, Shay | |
dc.contributor.author | Martín Gil, Alba | |
dc.contributor.author | Perez de Lara, María Jesús | |
dc.contributor.author | Pintor Just, Jesús Jerónimo | |
dc.contributor.author | Camden, Jean | |
dc.contributor.author | Weisman, Gary | |
dc.contributor.author | Lecka, Joanna | |
dc.contributor.author | Sévigny, Jean | |
dc.contributor.author | Fischer, Bilha | |
dc.date.accessioned | 2024-02-12T13:21:53Z | |
dc.date.available | 2024-02-12T13:21:53Z | |
dc.date.issued | 2010 | |
dc.description.abstract | Extracellular nucleotides can modify the production or drainage of the aqueous humor via activation of P2 receptors and therefore affect the intraocular pressure (IOP). We have synthesized slowly hydrolyzable nucleoside di- and triphosphate analogues, 1, and 8-14. Analogues 8-14 were completely resistant to hydrolysis by alkaline phosphatase over 30 min at 37 °C. In human blood serum, analogues 8-14 exhibited high stability, e.g., analogues 9 and 10-14 were only 15% and 0% degraded after 24 h, respectively. Moreover, analogues 8-14 were highly stable at pH 1.4 (t1/2 1 h-30 days). Analogues 8-14 were agonists of the P2Y1 receptor (EC50 0.57-9.54 μM). Ocular administration of most analogues into rabbits reduced IOP, e.g., analogue 9 reduced IOP by 32% (EC50 95.5 nM). Analogue 9 was more effective at reducing IOP than several common glaucoma drugs and represents a promising alternative to timolol maleate, which cannot be used for the treatment of patients suffering from asthma or cardiac problems. © 2010 American Chemical Society. | |
dc.description.department | Depto. de Optometría y Visión | |
dc.description.faculty | Fac. de Óptica y Optometría | |
dc.description.refereed | TRUE | |
dc.description.status | pub | |
dc.identifier.citation | Eliahu, Shay, et al. «2-MeS-β,γ-CCl2 -ATP Is a Potent Agent for Reducing Intraocular Pressure». Journal of Medicinal Chemistry, vol. 53, n.o 8, abril de 2010, pp. 3305-19. https://doi.org/10.1021/jm100030u. | |
dc.identifier.doi | 10.1021/jm100030u | |
dc.identifier.essn | 1520-4804 | |
dc.identifier.issn | 0022-2623 | |
dc.identifier.officialurl | https://doi.org/10.1021/jm100030u | |
dc.identifier.uri | https://hdl.handle.net/20.500.14352/101266 | |
dc.issue.number | 8 | |
dc.journal.title | Journal of Medicinal Chemistry | |
dc.language.iso | eng | |
dc.page.final | 3319 | |
dc.page.initial | 3305 | |
dc.publisher | ASC Publications | |
dc.rights.accessRights | open access | |
dc.subject.cdu | 612.842.6 | |
dc.subject.keyword | Presión intraocular | |
dc.subject.keyword | 2-MeS-β,γ-CCl2-ATP | |
dc.subject.ucm | Ciencias Biomédicas | |
dc.subject.unesco | 23 Química | |
dc.title | 2-MeS-β,γ-CCl2-ATP is a Potent Agent for Reducing Intraocular Pressure | |
dc.type | journal article | |
dc.type.hasVersion | AM | |
dc.volume.number | 53 | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 31c5901e-086a-4a75-8243-4baa56947752 | |
relation.isAuthorOfPublication | e8366c14-6aee-427c-8601-f6bf1e360010 | |
relation.isAuthorOfPublication.latestForDiscovery | 31c5901e-086a-4a75-8243-4baa56947752 |
Download
Original bundle
1 - 1 of 1